Effect of COVID-19 vaccine on blood glucose metrics in Arabic people with type 1 diabetes.

ABSTRACT:

Introduction

People with diabetes are at a higher risk for coronavirus disease-19 (COVID-19) and hence are prioritized for vaccination. The aim of the current study was to investigate the effects of COVID-19 vaccination on blood glucose control in Arabic people with type 1 diabetes (T1D). Secondary aim was to compare the responses between the two vaccines approved for use in Kuwait.

Method

This retrospective study compared ambulatory glucose metrics, using a continuous glucose monitoring device, measured for 14 days before, and 7 days and 14 days after, the first and second dose of the COVID-19 vaccine in Arabic people with Type 1 diabetes (T1D). We also explored possible links with vaccine type and other clinical characteristics. Glucose metrics calculated were time in rang

SUBMITTER: Al-Ozairi E 

PROVIDER: S-EPMC10067894 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature